EXAS
EXACT SCIENCES CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$104.91
+0.00%Sep 23, 2026, 11:30 UTC
An FDA advisory committee met to vote on whether the agency should approve Grail's Galleri multi-cancer blood test.
Jul 24, 2026, 19:58 UTC
A patient filed a class action lawsuit against Abbott Laboratories and Exact Sciences in Illinois federal court, alleging failure to safeguard sensitive personal and health information in a data theft hack claimed by ShinyHunters.
Source: